CapVest Recapitalizes Curium via New Continuation Vehicle
November 20, 2025
Curium and CapVest Partners LLP announced the recapitalization of Curium via a new Continuation Vehicle, valuing Curium at approximately $7 billion. The transaction is expected to be completed in Q1 2026, subject to regulatory approvals, and CapVest will remain the controlling shareholder.
- Buyers
- CapVest Partners LLP
- Targets
- Curium
- Industry
- Healthcare Services
- Location
- France
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Vestar Capital Launches $1.2B Continuation Vehicle for Circana (Blackstone, HarbourVest lead)
April 25, 2024
Data & Analytics
Vestar Capital Partners closed a $1.2 billion single-asset continuation vehicle to provide liquidity and committed capital for its stake in Circana. Blackstone Strategic Partners and HarbourVest Partners acted as lead investors in the vehicle, which is intended to offer existing investors optional liquidity while supporting Circana's organic and inorganic growth initiatives.
-
Summit Park Completes Majority Recapitalization of Curion
August 26, 2022
Data & Analytics
Summit Park has completed a majority recapitalization of Curion Holdings, LLC, a Chicago-based provider of product testing and consumer quantitative and qualitative insights. Stellus Capital Management provided senior debt financing and an equity co-investment to support the transaction; Summit Park said it will partner with Curion's management to expand the platform and grow the company's data-driven insights capabilities.
-
CapVest Acquires Recochem from H.I.G. Capital
November 6, 2023
Manufacturing
Funds managed by CapVest Partners LLP have acquired Recochem, a global manufacturer, marketer and distributor of aftermarket transportation and household fluids, from H.I.G. Capital, which will remain a minority investor. Recochem, headquartered in Montreal, Quebec, generates revenues in excess of $1 billion and CapVest plans to support further organic growth and M&A-driven expansion.
-
CapVest Acquires Majority Stake in STADA Arzneimittel
September 1, 2025
Healthcare Services
CapVest Partners LLP has completed its acquisition of a majority stake in STADA Arzneimittel AG, a global healthcare and pharmaceuticals company focused on consumer healthcare, generics, and specialty pharmaceuticals. CapVest and STADA plan to accelerate STADA’s global growth through both organic initiatives and strategic acquisitions.
-
Renovus Capital Partners Closes $325M Continuation Fund to Recapitalize Four Portfolio Companies
February 27, 2024
Professional Services
Renovus Capital Partners closed a $325 million multi-asset continuation fund to recapitalize four portfolio companies — Aretum, ClinicalMind, Lockstep Technology Group and Phoenix East Aviation — enabling existing LPs to realize gains while providing rollover capital and an incremental $60 million for strategic acquisitions. The fund was anchored by leading limited partners including New 2ND Capital, RCP Advisors, Blackstone Strategic Partners, Montana Capital Partners, Unigestion and Arcano Partners; Jefferies served as exclusive financial advisor and DLA Piper as legal counsel.
-
Vesey Street Capital Partners Majority Recapitalizes Inceptua Group
January 16, 2024
Healthcare Services
Vesey Street Capital Partners has completed a majority recapitalization of Luxembourg-headquartered Inceptua Group, a global pharmaceutical services provider specializing in clinical trial supplies and early access programs. As part of the transaction, industry veteran Doug Cook will join Inceptua as Executive Chairman to support the company's capability expansion and growth initiatives alongside CEO Stefan Fraenkel and founder Peter Krantz.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.